Patient-derived xenografts undergo mouse-specific tumor evolution

U Ben-David, G Ha, YY Tseng, NF Greenwald, C Oh… - Nature …, 2017 - nature.com
Patient-derived xenografts (PDXs) have become a prominent cancer model system, as they
are presumed to faithfully represent the genomic features of primary tumors. Here we …

Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases

Z Hu, Z Li, Z Ma, C Curtis - Nature genetics, 2020 - nature.com
Metastasis is the primary cause of cancer-related deaths, but the natural history, clonal
evolution and impact of treatment are poorly understood. We analyzed whole-exome …

[HTML][HTML] Genomic and clinical significance of multiple primary lung cancers as determined by next-generation sequencing

D Goodwin, V Rathi, M Conron, GM Wright - Journal of Thoracic Oncology, 2021 - Elsevier
Introduction Marked variations in survival rates have brought into question whether standard
clinicopathologic classification should be applied to patients presenting with multiple …

From Morphology to Molecules: Advances in the Distinction of Multiple Primary Lung Cancers From Intrapulmonary Metastases in Non–Small Cell Lung Cancer

GE Olteanu, I Kern, L Kalson… - Advances in Anatomic …, 2024 - journals.lww.com
The increasing incidence of multiple lung nodules underscores the need for precise
differentiation between multiple primary lung cancers (MPLCs) and intrapulmonary …

Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer

TL Leong, V Gayevskiy, DP Steinfort, MR De Massy… - Oncogene, 2019 - nature.com
Our understanding of genomic heterogeneity in lung cancer is largely based on the analysis
of early-stage surgical specimens. Here we used endoscopic sampling of paired primary …

Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes

A Di Federico, A De Giglio, F Gelsomino, D De Biase… - Cancers, 2022 - mdpi.com
Simple Summary Non-small cell lung cancer (NSCLC) patients harboring BRAF non-V600
alterations constitute a heterogeneous and poorly studied population orphan of targeted …

A platform-independent AI tumor lineage and site (ATLAS) classifier

NR Rydzewski, Y Shi, C Li, MR Chrostek… - Communications …, 2024 - nature.com
Histopathologic diagnosis and classification of cancer plays a critical role in guiding
treatment. Advances in next-generation sequencing have ushered in new complementary …

[HTML][HTML] Genomic evolution of lung cancer metastasis: current status and perspectives

WF Tang, R Fu, Y Liang, JS Lin, ZB Qiu… - Cancer …, 2021 - ncbi.nlm.nih.gov
Lung cancer is one of the cancers with the highest morbidity and mortality worldwide. Over
the two past decades, although the treatment of non-small cell lung cancer (NSCLC) has …

Lung cancer treatment potential and limits associated with the STAT family of transcription factors

P Faida, MKI Attiogbe, U Majeed, J Zhao, L Qu, D Fan - Cellular Signalling, 2023 - Elsevier
Lung cancer is one of the mortal cancers and the leading cause of cancer-related mortality,
with a cancer survival rate of fewer than 5% in develo** nations. This low survival rate can …

Power and pitfalls of computational methods for inferring clone phylogenies and mutation orders from bulk sequencing data

S Miura, T Vu, J Deng, T Buturla, O Oladeinde… - Scientific Reports, 2020 - nature.com
Tumors harbor extensive genetic heterogeneity in the form of distinct clone genotypes that
arise over time and across different tissues and regions in cancer. Many computational …